MindBio Therapeutics (XCNQ:MBIO) YoY EPS Growth : 150.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. MindBio Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 was 150.00%.

MindBio Therapeutics's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was C$0.00.

MindBio Therapeutics YoY EPS Growth Historical Data

The historical data trend for MindBio Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics YoY EPS Growth Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

YoY EPS Growth

31.37

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial					95.12	-	-	100.00	150.00

MindBio Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

MindBio Therapeutics's YoY EPS Growth for the fiscal year that ended in Jun. 2023 is calculated as:

	YoY EPS Growth (A: Jun. 2023 )
=	(Earnings per Share (Diluted) (A: Jun. 2023 )	-	Earnings per Share (Diluted) (A: Jun. 2022 ))	/	\| Earnings per Share (Diluted) (A: Jun. 2022 ) \|
=	(-0.035	-	-0.051)	/	\| -0.051 \|
=	31.37 %

MindBio Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(0.001	-	-0.002)	/	\| -0.002 \|
=	150.00 %

MindBio Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.